ReviewPharmacoEconomics2005
Economic evaluations of healthcare programmes and decision making: the influence of economic evaluations on different healthcare decision-making levels.
Review in PharmacoEconomics, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments.Health and quality of life outcomes · 2007Trial
- Article
- Clinical decision-making process and distributive justice: The mediating role of economic analysis. Empirical evidence from Italy.Journal of evaluation in clinical practice · 2025Article
- Considerations Around the Inclusion of Children and Young People's Time in Economic Evaluation: Findings from an International Delphi Study.PharmacoEconomics · 2024Article
- Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies.Expert review of pharmacoeconomics & outcomes research · 2024Review
- Synthesis of relevant information around non-core domains to support Multi-Criteria Decision Analysis (MCDA) for decision making.GMS health innovation and technologies · 2024Article
- Home Telemonitoring Technology for Patients With Heart Failure: Cost-Consequence Analysis of a Pilot Study.JMIR formative research · 2022Article
- Mapping of the World Health Organization's Disability Assessment Schedule 2.0 to disability weights using the Multi-Country Survey Study on Health and Responsiveness.International journal of methods in psychiatric research · 2021Article
- Introducing cell-free DNA noninvasive testing in a Down syndrome public health screening program: a budget impact analysis.Cost effectiveness and resource allocation : C/E · 2020Article
- Resource allocation in NHS dentistry: recognition of societal preferences (RAINDROP): study protocol.BMC health services research · 2018Article
- Integration of HIV Testing into Maternal, Newborn, and Child Health Weeks for Improved Case Finding and Linkage to Prevention of Mother-to-Child Transmission Services in Benue State, Nigeria.Frontiers in public health · 2017Article
- The use (or rather the non-use) of cost-effectiveness data in priority setting decisions - are we underestimating the barriers to using health economics in real world priority setting decisions?: Comment on "Use of cost-effectiveness data in priority setting decisions: experiences from the national guidelines for heart diseases in Sweden".International journal of health policy and management · 2015Article
- Impact on total population health and societal cost, and the implication on the actual cost-effectiveness of including tumour necrosis factor-α antagonists in management of ankylosing spondylitis: a dynamic population modelling study.Cost effectiveness and resource allocation : C/E · 2015Article
- Article
- From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmaking.Cost effectiveness and resource allocation : C/E · 2012Article
- Methodological quality of economic evaluations of new pharmaceuticals in The Netherlands.PharmacoEconomics · 2012Article
- The role of economic evaluation in the decision-making process of family physicians: design and methods of a qualitative embedded multiple-case study.BMC family practice · 2009Article
- Loss aversion and cost effectiveness of healthcare programmes: whose aversion counts anyway?PharmacoEconomics · 2008Article
- Economic evidence at the local level : options for making it more useful.PharmacoEconomics · 2007Article
- Systematic review of cost-effectiveness analysis of behavior change communication apps: Assessment of key methods.Digital healthReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Given the potential role of economic information in healthcare decision making, it is of interest to assess its influence on decisions at a national or regional level (macro level), at a healthcare facility level (meso level) and at the healthcare provider level (micro level). This literature review summarises 36 empirical studies that examined the influence of economic evaluations on these three healthcare decision-making levels. Economic evaluations are considered useful and important; however, their direct influence on decision making (instrumental use) is moderate, especially at the macro and micro levels. A major influence was observed at the meso level, leading to the conclusion that economic evaluations have the most pronounced influence on decision making within healthcare organisations. However, unexpectedly, our literature search did not reveal an empirical study analysing the considerable influence of economic evaluations on decisions by the National Institute of Health and Clinical Excellence in the UK. Our findings indicate that results of economic evaluations cannot be considered the dominant decision criterion for healthcare decision makers at either the macro, meso or micro levels. Enlightenment use (where scientific evidence provides a background of information, ideas and concepts that affect the way policy makers view problems and solutions) of economic evaluations in decision making remains to be proven.
Indexed as
Identifiers
16277545What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.